Brought to you by 
Novacea raises $36mm in Series B financing
09 Dec 2002
Executive Summary
Novacea (cancer therapy for solid tumors and hematologic malignancies) raised $36mm in its Series B round led by New Enterprise Associates (NEA) and Versant Ventures. Other investors included Domain Associates, ProQuest Investments, and Sofinnova Ventures.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Novacea raises $36mm in Series B financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice